BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Staiger H, Keuper M, Berti L, Hrabe de Angelis M, Häring HU. Fibroblast Growth Factor 21-Metabolic Role in Mice and Men. Endocr Rev 2017;38:468-88. [PMID: 28938407 DOI: 10.1210/er.2017-00016] [Cited by in Crossref: 113] [Cited by in F6Publishing: 115] [Article Influence: 28.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Y, Zhang L, Liang X, Zhang X, Chang J, Shi M, Liu H, Zhou Y, Sun Z, Zhao Y. Pyruvate Upregulates Hepatic FGF21 Expression by Activating PDE and Inhibiting cAMP–Epac–CREB Signaling Pathway. IJMS 2022;23:5490. [DOI: 10.3390/ijms23105490] [Reference Citation Analysis]
2 Neuschwander-Tetri BA. Therapeutic Landscape for NAFLD in 2020. Gastroenterology 2020;158:1984-1998.e3. [PMID: 32061596 DOI: 10.1053/j.gastro.2020.01.051] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
3 Li Y, Zhong W, Tang X. Strategies to Improve the Efficiency of Transplantation with Mesenchymal Stem Cells for the Treatment of Ischemic Stroke: A Review of Recent Progress. Stem Cells Int 2021;2021:9929128. [PMID: 34490053 DOI: 10.1155/2021/9929128] [Reference Citation Analysis]
4 Xia Q, Huang X, Huang J, Zheng Y, March ME, Li J, Wei Y. The Role of Autophagy in Skeletal Muscle Diseases. Front Physiol 2021;12:638983. [PMID: 33841177 DOI: 10.3389/fphys.2021.638983] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Lu H, Jia C, Wu D, Jin H, Lin Z, Pan J, Li X, Wang W. Fibroblast growth factor 21 (FGF21) alleviates senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the SIRT1-mTOR signaling pathway. Cell Death Dis 2021;12:865. [PMID: 34556628 DOI: 10.1038/s41419-021-04157-x] [Reference Citation Analysis]
6 Shroff T, Aina K, Maass C, Cipriano M, Lambrecht J, Tacke F, Mosig A, Loskill P. Studying metabolism with multi-organ chips: new tools for disease modelling, pharmacokinetics and pharmacodynamics. Open Biol 2022;12:210333. [PMID: 35232251 DOI: 10.1098/rsob.210333] [Reference Citation Analysis]
7 Stöhr O, Tao R, Miao J, Copps KD, White MF. FoxO1 suppresses Fgf21 during hepatic insulin resistance to impair peripheral glucose utilization and acute cold tolerance. Cell Rep 2021;34:108893. [PMID: 33761350 DOI: 10.1016/j.celrep.2021.108893] [Reference Citation Analysis]
8 Schumacher JD, Guo GL. Pharmacologic Modulation of Bile Acid-FXR-FGF15/FGF19 Pathway for the Treatment of Nonalcoholic Steatohepatitis. Handb Exp Pharmacol 2019;256:325-57. [PMID: 31201553 DOI: 10.1007/164_2019_228] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
9 Fiorucci S, Distrutti E. Linking liver metabolic and vascular disease via bile acid signaling. Trends Mol Med 2022;28:51-66. [PMID: 34815180 DOI: 10.1016/j.molmed.2021.10.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Wu CC, Hung CJ, Wang YY, Lin SY, Chen WY, Kuan YH, Liao SL, Yang CP, Chen CJ. Propofol Improved Glucose Tolerance Associated with Increased FGF-21 and GLP-1 Production in Male Sprague-Dawley Rats. Molecules 2020;25:E3229. [PMID: 32679813 DOI: 10.3390/molecules25143229] [Reference Citation Analysis]
11 Fernández-Mincone T, Contreras-Briceño F, Espinosa-Ramírez M, García-Valdés P, López-Fuenzalida A, Riquelme A, Arab JP, Cabrera D, Arrese M, Barrera F. Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications. Expert Rev Gastroenterol Hepatol 2020;14:1141-57. [PMID: 32811209 DOI: 10.1080/17474124.2020.1810563] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Liu J, Dalamaga M. Emerging roles for stress kinase p38 and stress hormone fibroblast growth factor 21 in NAFLD development. Metabol Open 2021;12:100153. [PMID: 34917917 DOI: 10.1016/j.metop.2021.100153] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chou Y, Ma J, Su X, Zhong Y. Emerging insights into the relationship between hyperlipidemia and the risk of diabetic retinopathy. Lipids Health Dis 2020;19:241. [PMID: 33213461 DOI: 10.1186/s12944-020-01415-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Hollstein T, Piaggi P. Metabolic Factors Determining the Susceptibility to Weight Gain: Current Evidence. Curr Obes Rep 2020;9:121-35. [PMID: 32248352 DOI: 10.1007/s13679-020-00371-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
15 Alqahtani SA, Schattenberg JM. NAFLD in the Elderly. Clin Interv Aging 2021;16:1633-49. [PMID: 34548787 DOI: 10.2147/CIA.S295524] [Reference Citation Analysis]
16 Demerdash HM. Weight regain after bariatric surgery: Promoters and potential predictors. World J Meta-Anal 2021; 9(5): 438-454 [DOI: 10.13105/wjma.v9.i5.438] [Reference Citation Analysis]
17 Stone SI, Wegner DJ, Wambach JA, Cole FS, Urano F, Ornitz DM. Digenic Variants in the FGF21 Signaling Pathway Associated with Severe Insulin Resistance and Pseudoacromegaly. J Endocr Soc 2020;4:bvaa138. [PMID: 33210059 DOI: 10.1210/jendso/bvaa138] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908-922. [PMID: 29967350 DOI: 10.1038/s41591-018-0104-9] [Cited by in Crossref: 777] [Cited by in F6Publishing: 742] [Article Influence: 194.3] [Reference Citation Analysis]
19 Rhyu J, Yu R. Newly discovered endocrine functions of the liver. World J Hepatol 2021; 13(11): 1611-1628 [PMID: 34904032 DOI: 10.4254/wjh.v13.i11.1611] [Reference Citation Analysis]
20 Somm E, Jornayvaz FR. Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives. Endocr Rev 2018;39:960-89. [PMID: 30124818 DOI: 10.1210/er.2018-00134] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
21 Telgenkamp I, Kusters YHAM, Schalkwijk CG, Houben AJHM, Kooi ME, Lindeboom L, Bons JAP, Schaper NC, Joris PJ, Plat J, Mensink RP, Stehouwer CDA, Brouwers MCGJ. Contribution of Liver Fat to Weight Loss-Induced Changes in Serum Hepatokines: A Randomized Controlled Trial. J Clin Endocrinol Metab 2019;104:2719-27. [PMID: 30753672 DOI: 10.1210/jc.2018-02378] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
22 Bryl A, Mrugacz M, Falkowski M, Zorena K. The Effect of Hyperlipidemia on the Course of Diabetic Retinopathy—Literature Review. JCM 2022;11:2761. [DOI: 10.3390/jcm11102761] [Reference Citation Analysis]
23 Mutsnaini L, Kim CS, Kim J, Joe Y, Chung HT, Choi HS, Roh E, Kim MS, Yu R. Fibroblast growth factor 21 deficiency aggravates obesity-induced hypothalamic inflammation and impairs thermogenic response. Inflamm Res 2019;68:351-8. [PMID: 30863887 DOI: 10.1007/s00011-019-01222-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
24 Abdelmalek MF, Charles ED, Sanyal AJ, Harrison SA, Neuschwander-Tetri BA, Goodman Z, Ehman RA, Karsdal M, Nakajima A, Du S, Tirucherai GS, Klinger GH, Mora J, Yamaguchi M, Shevell DE, Loomba R. The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with nonalcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis. Contemp Clin Trials 2021;104:106335. [PMID: 33657443 DOI: 10.1016/j.cct.2021.106335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Tomita Y, Ozawa N, Miwa Y, Ishida A, Ohta M, Tsubota K, Kurihara T. Pemafibrate Prevents Retinal Pathological Neovascularization by Increasing FGF21 Level in a Murine Oxygen-Induced Retinopathy Model. Int J Mol Sci 2019;20:E5878. [PMID: 31771164 DOI: 10.3390/ijms20235878] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
26 Blanco AM, Bertucci JI, Unniappan S. FGF21 Mimics a Fasting-Induced Metabolic State and Increases Appetite in Zebrafish. Sci Rep 2020;10:6993. [PMID: 32332781 DOI: 10.1038/s41598-020-63726-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
27 Di Ciaula A, Passarella S, Shanmugam H, Noviello M, Bonfrate L, Wang DQ, Portincasa P. Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies? Int J Mol Sci 2021;22:5375. [PMID: 34065331 DOI: 10.3390/ijms22105375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Biagioli M, Carino A, Fiorucci C, Annunziato G, Marchianò S, Bordoni M, Roselli R, Giorgio CD, Castiglione F, Ricci P, Bruno A, Faccini A, Distrutti E, Baldoni M, Costantino G, Fiorucci S. The Aryl Hydrocarbon Receptor (AhR) Mediates the Counter-Regulatory Effects of Pelargonidins in Models of Inflammation and Metabolic Dysfunctions. Nutrients 2019;11:E1820. [PMID: 31394746 DOI: 10.3390/nu11081820] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
29 Magno AL, Herat LY, Kiuchi MG, Schlaich MP, Ward NC, Matthews VB. The Influence of Hypertensive Therapies on Circulating Factors: Clinical Implications for SCFAs, FGF21, TNFSF14 and TNF-α. J Clin Med 2020;9:E2764. [PMID: 32858953 DOI: 10.3390/jcm9092764] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Deprince A, Haas JT, Staels B. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol Metab 2020;42:101092. [PMID: 33010471 DOI: 10.1016/j.molmet.2020.101092] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
31 Xiong Y, Chen Y, Liu Y, Zhang B. Moderate-Intensity Continuous Training Improves FGF21 and KLB Expression in Obese Mice. Biochemistry (Mosc) 2020;85:938-46. [PMID: 33045954 DOI: 10.1134/S000629792008009X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 De Bandt JP, Jegatheesan P, Tennoune-El-Hafaia N. Muscle Loss in Chronic Liver Diseases: The Example of Nonalcoholic Liver Disease. Nutrients 2018;10:E1195. [PMID: 30200408 DOI: 10.3390/nu10091195] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
33 Linares GR, Leng Y, Maric D, Chuang DM. Overexpression of fibroblast growth factor-21 (FGF-21) protects mesenchymal stem cells against caspase-dependent apoptosis induced by oxidative stress and inflammation. Cell Biol Int 2020;44:2163-9. [PMID: 32557962 DOI: 10.1002/cbin.11409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
34 Kim TH, Hong DG, Yang YM. Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism. Biomedicines 2021;9:1903. [PMID: 34944728 DOI: 10.3390/biomedicines9121903] [Reference Citation Analysis]
35 Aleem M, Maqsood H, Younus S, Zafar AF, Talpur AS, Shakeel H. Fibroblast Growth Factor 21 and Its Association With Oxidative Stress and Lipid Profile in Type 2 Diabetes Mellitus. Cureus 2021;13:e17723. [PMID: 34659937 DOI: 10.7759/cureus.17723] [Reference Citation Analysis]
36 Johansson KS, Sonne DP, Knop FK, Christensen MB. What is on the horizon for type 2 diabetes pharmacotherapy? – An overview of the antidiabetic drug development pipeline. Expert Opinion on Drug Discovery 2020;15:1253-65. [DOI: 10.1080/17460441.2020.1791078] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
37 Zheng W, Matei N, Pang J, Luo X, Song Z, Tang J, Zhang JH. Delayed recanalization at 3 days after permanent MCAO attenuates neuronal apoptosis through FGF21/FGFR1/PI3K/Caspase-3 pathway in rats. Exp Neurol 2019;320:113007. [PMID: 31295445 DOI: 10.1016/j.expneurol.2019.113007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
38 Lee D, Tomita Y, Miwa Y, Jeong H, Mori K, Tsubota K, Kurihara T. Fenofibrate Protects against Retinal Dysfunction in a Murine Model of Common Carotid Artery Occlusion-Induced Ocular Ischemia. Pharmaceuticals (Basel) 2021;14:223. [PMID: 33799938 DOI: 10.3390/ph14030223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
39 Watt MJ, Miotto PM, De Nardo W, Montgomery MK. The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance. Endocr Rev. 2019;40:1367-1393. [PMID: 31098621 DOI: 10.1210/er.2019-00034] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 33.0] [Reference Citation Analysis]
40 Alipoor E, Mohammad Hosseinzadeh F, Hosseinzadeh-Attar MJ. Adipokines in critical illness: A review of the evidence and knowledge gaps. Biomed Pharmacother 2018;108:1739-50. [PMID: 30372877 DOI: 10.1016/j.biopha.2018.09.165] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
41 Wang HW, Jiang X, Zhang Y, Wang J, Xie J, Wang YQ, Li YH. FGF21 Protects Against Hypoxia Injury Through Inducing HSP72 in Cerebral Microvascular Endothelial Cells. Front Pharmacol 2019;10:101. [PMID: 30842736 DOI: 10.3389/fphar.2019.00101] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
42 Fiorucci S, Biagioli M, Baldoni M, Ricci P, Sepe V, Zampella A, Distrutti E. The identification of farnesoid X receptor modulators as treatment options for nonalcoholic fatty liver disease. Expert Opin Drug Discov 2021;:1-16. [PMID: 33849361 DOI: 10.1080/17460441.2021.1916465] [Reference Citation Analysis]
43 Suassuna PGDA, de Paula RB, Sanders-pinheiro H, Moe OW, Hu M. Fibroblast growth factor 21 in chronic kidney disease. J Nephrol 2019;32:365-77. [DOI: 10.1007/s40620-018-0550-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
44 Priest C, Tontonoz P. Inter-organ cross-talk in metabolic syndrome. Nat Metab 2019;1:1177-88. [PMID: 32694672 DOI: 10.1038/s42255-019-0145-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
45 Li Y, Lin M, Lin P, Xia N, Li X, Lin L, Yang Y. Maternal High-Fat Diet Alters the Characteristics of Astrocytes and Worsens the Outcome of Stroke in Rat Offspring, Which Improves After FGF21 Administration. Front Cell Dev Biol 2021;9:731698. [PMID: 35096806 DOI: 10.3389/fcell.2021.731698] [Reference Citation Analysis]
46 Zhang X, Yang L, Xu X, Tang F, Yi P, Qiu B, Hao Y. A review of fibroblast growth factor 21 in diabetic cardiomyopathy. Heart Fail Rev 2019;24:1005-17. [PMID: 31175491 DOI: 10.1007/s10741-019-09809-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
47 Cooper JF, Guasp RJ, Arnold ML, Grant BD, Driscoll M. Stress increases in exopher-mediated neuronal extrusion require lipid biosynthesis, FGF, and EGF RAS/MAPK signaling. Proc Natl Acad Sci U S A 2021;118:e2101410118. [PMID: 34475208 DOI: 10.1073/pnas.2101410118] [Reference Citation Analysis]
48 Shi Y, Wang S, Peng H, Lv Y, Li W, Cheng S, Liu J. Fibroblast Growth Factor 21 Attenuates Vascular Calcification by Alleviating Endoplasmic Reticulum Stress Mediated Apoptosis in Rats. Int J Biol Sci 2019;15:138-47. [PMID: 30662354 DOI: 10.7150/ijbs.28873] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
49 Zhu L, Li M, Zha Q, Yang M, Yu J, Pan M, Yin Q, Jiang L, Xia M, Liu BC, Wang B. Fibroblast growth factor 21 (FGF21) is a sensitive marker of osteoporosis in haemodialysis patients: a cross-sectional observational study. BMC Nephrol 2021;22:183. [PMID: 34011291 DOI: 10.1186/s12882-021-02393-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Biagioli M, Fiorucci S. Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease. Liver Research 2021;5:119-41. [DOI: 10.1016/j.livres.2021.08.003] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Basolo A, Begaye B, Hollstein T, Vinales KL, Walter M, Santini F, Krakoff J, Piaggi P. Effects of Short-Term Fasting and Different Overfeeding Diets on Thyroid Hormones in Healthy Humans. Thyroid 2019;29:1209-19. [PMID: 31298652 DOI: 10.1089/thy.2019.0237] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
52 Hajny S, Borup A, Elsøe S, Christoffersen C. Increased plasma apoM levels impair triglyceride turnover in mice. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158969. [PMID: 34051379 DOI: 10.1016/j.bbalip.2021.158969] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
53 Gehring J, Azzout-Marniche D, Chaumontet C, Piedcoq J, Gaudichon C, Even PC. Protein-carbohydrate interaction effects on energy balance, FGF21, IGF-1, and hypothalamic gene expression in rats. Am J Physiol Endocrinol Metab 2021;321:E621-35. [PMID: 34569272 DOI: 10.1152/ajpendo.00246.2021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Badakhshi Y, Shao W, Liu D, Tian L, Pang J, Gu J, Hu J, Jin T. Estrogen-Wnt signaling cascade regulates expression of hepatic fibroblast growth factor 21. Am J Physiol Endocrinol Metab 2021;321:E292-304. [PMID: 34229476 DOI: 10.1152/ajpendo.00638.2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
55 Hui Q, Jin Z, Li X, Liu C, Wang X. FGF Family: From Drug Development to Clinical Application. Int J Mol Sci 2018;19:E1875. [PMID: 29949887 DOI: 10.3390/ijms19071875] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 10.5] [Reference Citation Analysis]
56 Wu Y, Shi T, Wang J, He R. Talabostat Alleviates Obesity and Associated Metabolic Dysfunction via Suppression of Macrophage-Driven Adipose Inflammation. Obesity (Silver Spring) 2021;29:327-36. [PMID: 33342076 DOI: 10.1002/oby.23058] [Reference Citation Analysis]
57 Chiu L, Hung C, Lin L, Lin Y, Hsu B, D'elia L. Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance Hemodialysis. International Journal of Hypertension 2022;2022:1-8. [DOI: 10.1155/2022/7098458] [Reference Citation Analysis]
58 Liu D, Pang J, Shao W, Gu J, Zeng Y, He HH, Ling W, Qian X, Jin T. Hepatic Fibroblast Growth Factor 21 Is Involved in Mediating Functions of Liraglutide in Mice With Dietary Challenge. Hepatology 2021;74:2154-69. [PMID: 33851458 DOI: 10.1002/hep.31856] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
59 Chang JS, Namkung J. Effects of Exercise Intervention on Mitochondrial Stress Biomarkers in Metabolic Syndrome Patients: A Randomized Controlled Trial. Int J Environ Res Public Health 2021;18:2242. [PMID: 33668309 DOI: 10.3390/ijerph18052242] [Reference Citation Analysis]
60 Keuper M, Häring HU, Staiger H. Circulating FGF21 Levels in Human Health and Metabolic Disease. Exp Clin Endocrinol Diabetes 2020;128:752-70. [PMID: 31108554 DOI: 10.1055/a-0879-2968] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
61 Usui N, Yoshida M, Takayanagi Y, Nasanbuyan N, Inutsuka A, Kurosu H, Mizukami H, Mori Y, Kuro-O M, Onaka T. Roles of fibroblast growth factor 21 in the control of depression-like behaviours after social defeat stress in male rodents. J Neuroendocrinol 2021;33:e13026. [PMID: 34472154 DOI: 10.1111/jne.13026] [Reference Citation Analysis]
62 Tezze C, Romanello V, Sandri M. FGF21 as Modulator of Metabolism in Health and Disease. Front Physiol 2019;10:419. [PMID: 31057418 DOI: 10.3389/fphys.2019.00419] [Cited by in Crossref: 82] [Cited by in F6Publishing: 78] [Article Influence: 27.3] [Reference Citation Analysis]
63 Serafine KM, O'Dell LE, Zorrilla EP. Converging vulnerability factors for compulsive food and drug use. Neuropharmacology 2021;196:108556. [PMID: 33862029 DOI: 10.1016/j.neuropharm.2021.108556] [Reference Citation Analysis]
64 Xie T, Leung PS. Roles of FGF21 and irisin in obesity-related diabetes and pancreatic diseases. Journal of Pancreatology 2020;3:29-34. [DOI: 10.1097/jp9.0000000000000039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Ebrahimi F, Urwyler SA, Betz MJ, Christ ER, Schuetz P, Mueller B, Donath MY, Christ-Crain M. Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome. Sci Rep 2021;11:7911. [PMID: 33846498 DOI: 10.1038/s41598-021-87207-w] [Reference Citation Analysis]
66 Prevot V, Nogueiras R, Schwaninger M. Tanycytes in the infundibular nucleus and median eminence and their role in the blood-brain barrier. Handb Clin Neurol 2021;180:253-73. [PMID: 34225934 DOI: 10.1016/B978-0-12-820107-7.00016-1] [Reference Citation Analysis]
67 Funcke JB, Scherer PE. Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication. J Lipid Res 2019;60:1648-84. [PMID: 31209153 DOI: 10.1194/jlr.R094060] [Cited by in Crossref: 57] [Cited by in F6Publishing: 29] [Article Influence: 19.0] [Reference Citation Analysis]
68 Li X, Shen H, Zhou T, Cao X, Chen Y, Liang Y, Lu T, He J, Dou Z, Liu C, Tang Y, Zhu Z. Does an increase in serum FGF21 level predict 28-day mortality of critical patients with sepsis and ARDS? Respir Res 2021;22:182. [PMID: 34154595 DOI: 10.1186/s12931-021-01778-w] [Reference Citation Analysis]
69 Wang Z, Yuan M, Xu C, Zhang Y, Ying C, Xiao X. FGF21 Serum Levels in the Early Second Trimester Are Positively Correlated With the Risk of Subsequent Gestational Diabetes Mellitus: A Propensity-Matched Nested Case-Control Study. Front Endocrinol (Lausanne) 2021;12:630287. [PMID: 33995273 DOI: 10.3389/fendo.2021.630287] [Reference Citation Analysis]
70 Mana MF, Parisi MCR, Correa-Giannella ML, Neto AM, Yamanaka A, Cunha-Silva M, Cavaleiro AM, Dos Santos CR, Pavan CR, Sevá-Pereira T, Dertkigil SSJ, Mazo DF. Non-Alcoholic Fatty Liver Disease in Long-Term Type 2 Diabetes: Role of rs738409 PNPLA3 and rs499765 FGF21 Polymorphisms and Serum Biomarkers. Molecules 2022;27:3193. [PMID: 35630668 DOI: 10.3390/molecules27103193] [Reference Citation Analysis]
71 Tomita Y, Lee D, Miwa Y, Jiang X, Ohta M, Tsubota K, Kurihara T. Pemafibrate Protects Against Retinal Dysfunction in a Murine Model of Diabetic Retinopathy. Int J Mol Sci 2020;21:E6243. [PMID: 32872333 DOI: 10.3390/ijms21176243] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
72 Javed K, Fairweather SJ. Amino acid transporters in the regulation of insulin secretion and signalling. Biochem Soc Trans 2019;47:571-90. [PMID: 30936244 DOI: 10.1042/BST20180250] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
73 Wang Q, Sharma VP, Shen H, Xiao Y, Zhu Q, Xiong X, Guo L, Jiang L, Ohta K, Li S, Shi H, Rui L, Lin JD. The hepatokine Tsukushi gates energy expenditure via brown fat sympathetic innervation. Nat Metab 2019;1:251-60. [PMID: 31535079 DOI: 10.1038/s42255-018-0020-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
74 Grattagliano I, Di Ciaula A, Baj J, Molina-Molina E, Shanmugam H, Garruti G, Wang DQ, Portincasa P. Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD). Methods Mol Biol 2021;2310:201-46. [PMID: 34096005 DOI: 10.1007/978-1-0716-1433-4_12] [Reference Citation Analysis]
75 Heianza Y, Qi L. Impact of Genes and Environment on Obesity and Cardiovascular Disease. Endocrinology 2019;160:81-100. [PMID: 30517623 DOI: 10.1210/en.2018-00591] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
76 Klímová J, Zelinka T, Rosa J, Štrauch B, Haluzíková D, Haluzík M, Holaj R, Krátká Z, Kvasnička J, Ďurovcová V, Matoulek M, Novák K, Michalský D, Widimský J Jr, Petrák O. FGF21 Levels in Pheochromocytoma/Functional Paraganglioma. Cancers (Basel) 2019;11:E485. [PMID: 30959789 DOI: 10.3390/cancers11040485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
77 Vázquez P, Hernández-Sánchez C, Escalona-Garrido C, Pereira L, Contreras C, López M, Balsinde J, de Pablo F, Valverde ÁM. Increased FGF21 in brown adipose tissue of tyrosine hydroxylase heterozygous mice: implications for cold adaptation. J Lipid Res 2018;59:2308-20. [PMID: 30352954 DOI: 10.1194/jlr.M085209] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
78 Hu X, Guo F. Amino Acid Sensing in Metabolic Homeostasis and Health. Endocr Rev 2020:bnaa026. [PMID: 33053153 DOI: 10.1210/endrev/bnaa026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
79 Alemán G, Castro AL, Vigil-Martínez A, Torre-Villalvazo I, Díaz-Villaseñor A, Noriega LG, Medina-Vera I, Ordáz G, Torres N, Tovar AR. Interaction between the amount of dietary protein and the environmental temperature on the expression of browning markers in adipose tissue of rats. Genes Nutr 2019;14:19. [PMID: 31178938 DOI: 10.1186/s12263-019-0642-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
80 Purhonen J, Grigorjev V, Ekiert R, Aho N, Rajendran J, Pietras R, Truvé K, Wikström M, Sharma V, Osyczka A, Fellman V, Kallijärvi J. A spontaneous mitonuclear epistasis converging on Rieske Fe-S protein exacerbates complex III deficiency in mice. Nat Commun 2020;11:322. [PMID: 31949167 DOI: 10.1038/s41467-019-14201-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
81 Wada Y, Izumi H, Shimizu T, Takeda Y. A More Oxidized Plasma Albumin Redox State and Lower Plasma HDL Particle Number Reflect Low-Protein Diet Ingestion in Adult Rats. J Nutr 2020;150:256-66. [PMID: 31552421 DOI: 10.1093/jn/nxz223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Homer-Bouthiette C, Xiao L, Hurley MM. Gait disturbances and muscle dysfunction in fibroblast growth factor 2 knockout mice. Sci Rep 2021;11:11005. [PMID: 34040128 DOI: 10.1038/s41598-021-90565-0] [Reference Citation Analysis]
83 Schnapp G, Hoevels Y, Bakker RA, Schreiner P, Klein T, Nar H. A Single Second Shell Amino Acid Determines Affinity and Kinetics of Linagliptin Binding to Type 4 Dipeptidyl Peptidase and Fibroblast Activation Protein. ChemMedChem 2021;16:630-9. [PMID: 33030297 DOI: 10.1002/cmdc.202000591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
84 Shao W, Jin T. Hepatic hormone FGF21 and its analogues in clinical trials. Chronic Diseases and Translational Medicine 2021. [DOI: 10.1016/j.cdtm.2021.08.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
85 Paroni G, Panza F, De Cosmo S, Greco A, Seripa D, Mazzoccoli G. Klotho at the Edge of Alzheimer’s Disease and Senile Depression. Mol Neurobiol 2019;56:1908-20. [DOI: 10.1007/s12035-018-1200-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
86 Siekacz K, Piotrowski WJ, Iwański MA, Górski P, Białas AJ. The Role of Interaction between Mitochondria and the Extracellular Matrix in the Development of Idiopathic Pulmonary Fibrosis. Oxid Med Cell Longev 2021;2021:9932442. [PMID: 34707784 DOI: 10.1155/2021/9932442] [Reference Citation Analysis]
87 Manandhar M, Chun E, Romesberg FE. Genetic Code Expansion: Inception, Development, Commercialization. J Am Chem Soc 2021;143:4859-78. [DOI: 10.1021/jacs.0c11938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Liu XH, Graham ZA, Harlow L, Pan J, Azulai D, Bauman WA, Yarrow J, Cardozo CP. Spinal Cord Injury Reduces Serum Levels of Fibroblast Growth Factor-21 and Impairs Its Signaling Pathways in Liver and Adipose Tissue in Mice. Front Endocrinol (Lausanne) 2021;12:668984. [PMID: 34046014 DOI: 10.3389/fendo.2021.668984] [Reference Citation Analysis]
89 Carroll HA, Chen YC, Templeman I, James LJ, Betts JA, Trim WV. The effect of hydration status on plasma FGF21 concentrations in humans: A subanalysis of a randomised crossover trial. PLoS One 2020;15:e0235557. [PMID: 32756564 DOI: 10.1371/journal.pone.0235557] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
90 Perreault L, Skyler JS, Rosenstock J. Novel therapies with precision mechanisms for type 2 diabetes mellitus. Nat Rev Endocrinol 2021;17:364-77. [PMID: 33948015 DOI: 10.1038/s41574-021-00489-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
91 Sun H, Sherrier M, Li H. Skeletal Muscle and Bone - Emerging Targets of Fibroblast Growth Factor-21. Front Physiol 2021;12:625287. [PMID: 33762965 DOI: 10.3389/fphys.2021.625287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
92 Wu X, Xie G, Xu X, Wu W, Yang B. Adverse bioeffect of perfluorooctanoic acid on liver metabolic function in mice. Environ Sci Pollut Res Int 2018;25:4787-93. [PMID: 29198028 DOI: 10.1007/s11356-017-0872-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
93 Panaro BL, Coppage AL, Beaudry JL, Varin EM, Kaur K, Lai JH, Wu W, Liu Y, Bachovchin WW, Drucker DJ. Fibroblast activation protein is dispensable for control of glucose homeostasis and body weight in mice. Mol Metab 2019;19:65-74. [PMID: 30477988 DOI: 10.1016/j.molmet.2018.10.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
94 Chiu L, Wang C, Lin Y, Hsu B. Association of serum fibroblast growth factor 21 levels with skeletal muscle mass and mortality in chronic hemodialysis patients. Journal of the Formosan Medical Association 2022. [DOI: 10.1016/j.jfma.2022.05.007] [Reference Citation Analysis]
95 Xiong X, Wang Q, Wang S, Zhang J, Liu T, Guo L, Yu Y, Lin JD. Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi. Mol Metab 2019;20:128-37. [PMID: 30595550 DOI: 10.1016/j.molmet.2018.12.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
96 Katsiki N, Mantzoros C. Fibroblast growth factor 21: A role in cardiometabolic disorders and cardiovascular risk prediction? Metabolism 2019;93:iii-v. [PMID: 30659799 DOI: 10.1016/j.metabol.2019.01.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
97 Xiao F, Zeng J, Huang P, Yan B, Zeng X, Liu C, Shi X, Wang L, Song H, Lin M, Yang S, Li Z, Li X, Liu C. Independent Association of Serum Fibroblast Growth Factor 21 Levels With Impaired Liver Enzymes in Hyperthyroid Patients. Front Endocrinol (Lausanne) 2018;9:800. [PMID: 30692965 DOI: 10.3389/fendo.2018.00800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
98 Chen J, Hu J, Liu H, Xiong Y, Zou Y, Huang W, Shao M, Wu J, Yu L, Wang X, Wang X, Lin L. FGF21 Protects the Blood-Brain Barrier by Upregulating PPARγ via FGFR1/β-klotho after Traumatic Brain Injury. J Neurotrauma 2018;35:2091-103. [PMID: 29648978 DOI: 10.1089/neu.2017.5271] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 8.5] [Reference Citation Analysis]
99 Søberg S, Andersen ES, Dalsgaard NB, Jarlhelt I, Hansen NL, Hoffmann N, Vilsbøll T, Chenchar A, Jensen M, Grevengoed TJ, Trammell SAJ, Knop FK, Gillum MP. FGF21, a liver hormone that inhibits alcohol intake in mice, increases in human circulation after acute alcohol ingestion and sustained binge drinking at Oktoberfest. Mol Metab 2018;11:96-103. [PMID: 29627377 DOI: 10.1016/j.molmet.2018.03.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
100 Lee D, Tomita Y, Jeong H, Miwa Y, Tsubota K, Negishi K, Kurihara T. Pemafibrate Prevents Retinal Dysfunction in a Mouse Model of Unilateral Common Carotid Artery Occlusion. Int J Mol Sci 2021;22:9408. [PMID: 34502311 DOI: 10.3390/ijms22179408] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Geißler C, Krause C, Neumann AM, Britsemmer JH, Taege N, Grohs M, Kaehler M, Cascorbi I, Lewis AG, Seeley RJ, Oster H, Kirchner H. Dietary induction of obesity and insulin resistance is associated with changes in Fgf21 DNA methylation in liver of mice. J Nutr Biochem 2021;100:108907. [PMID: 34801693 DOI: 10.1016/j.jnutbio.2021.108907] [Reference Citation Analysis]
102 Liao YJ, Wang YH, Wu CY, Hsu FY, Chien CY, Lee YC. Ketogenic Diet Enhances the Cholesterol Accumulation in Liver and Augments the Severity of CCl4 and TAA-Induced Liver Fibrosis in Mice. Int J Mol Sci 2021;22:2934. [PMID: 33805788 DOI: 10.3390/ijms22062934] [Reference Citation Analysis]
103 Allard C, Bonnet F, Xu B, Coons L, Albarado D, Hill C, Fagherazzi G, Korach KS, Levin ER, Lefante J, Morrison C, Mauvais-Jarvis F. Activation of hepatic estrogen receptor-α increases energy expenditure by stimulating the production of fibroblast growth factor 21 in female mice. Mol Metab 2019;22:62-70. [PMID: 30797705 DOI: 10.1016/j.molmet.2019.02.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
104 Płatek T, Polus A, Góralska J, Raźny U, Dziewońska A, Micek A, Dembińska-Kieć A, Solnica B, Malczewska-Malec M. Epigenetic Regulation of Processes Related to High Level of Fibroblast Growth Factor 21 in Obese Subjects. Genes (Basel) 2021;12:307. [PMID: 33670024 DOI: 10.3390/genes12020307] [Reference Citation Analysis]
105 Geller S, Arribat Y, Netzahualcoyotzi C, Lagarrigue S, Carneiro L, Zhang L, Amati F, Lopez-mejia IC, Pellerin L. Tanycytes Regulate Lipid Homeostasis by Sensing Free Fatty Acids and Signaling to Key Hypothalamic Neuronal Populations via FGF21 Secretion. Cell Metabolism 2019;30:833-844.e7. [DOI: 10.1016/j.cmet.2019.08.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
106 Herpich C, Haß U, Kochlik B, Franz K, Laeger T, Klaus S, Bosy-Westphal A, Norman K. Postprandial dynamics and response of fibroblast growth factor 21 in older adults. Clin Nutr 2021;40:3765-71. [PMID: 34130022 DOI: 10.1016/j.clnu.2021.04.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
107 Taniguchi H, Shimizu K, Wada S, Nirengi S, Kataoka H, Higashi A. Effects of beta-conglycinin intake on circulating FGF21 levels and brown adipose tissue activity in Japanese young men: a single intake study and a randomized controlled trial. J Physiol Anthropol 2020;39:17. [PMID: 32698903 DOI: 10.1186/s40101-020-00226-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Mäkelä AM, Hohtola E, Miinalainen IJ, Autio JA, Schmitz W, Niemi KJ, Hiltunen JK, Autio KJ. Mitochondrial 2,4-dienoyl-CoA reductase (Decr) deficiency and impairment of thermogenesis in mouse brown adipose tissue. Sci Rep 2019;9:12038. [PMID: 31427678 DOI: 10.1038/s41598-019-48562-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
109 Tas E, Bai S, Ou X, Mercer K, Lin H, Mansfield K, Buchmann R, Diaz EC, Oden J, Børsheim E, Adams SH, Dranoff J. Fibroblast Growth Factor-21 to Adiponectin Ratio: A Potential Biomarker to Monitor Liver Fat in Children With Obesity. Front Endocrinol (Lausanne) 2020;11:654. [PMID: 33071964 DOI: 10.3389/fendo.2020.00654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
110 Zhuo Y, Hua L, Feng B, Jiang X, Li J, Jiang D, Huang X, Zhu Y, Li Z, Yan L, Jin C, Che L, Fang Z, Lin Y, Xu S, Li J, Wu. Fibroblast growth factor 21 coordinates adiponectin to mediate the beneficial effects of low-protein diet on primordial follicle reserve. EBioMedicine 2019;41:623-35. [PMID: 30772303 DOI: 10.1016/j.ebiom.2019.02.020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
111 Cho JM, Yang EH, Quan W, Nam EH, Cheon HG. Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects. Sci Rep 2020;10:21280. [PMID: 33277568 DOI: 10.1038/s41598-020-77978-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
112 Fonseca M, Soares R, Coelho P. Lower melanoma pulmonary metastatic burden in obese mice: role of FGF-21. Melanoma Res 2021;31:515-25. [PMID: 34524221 DOI: 10.1097/CMR.0000000000000781] [Reference Citation Analysis]
113 Herz CT, Kiefer FW. Adipose tissue browning in mice and humans. Journal of Endocrinology 2019;241:R97-R109. [DOI: 10.1530/joe-18-0598] [Cited by in Crossref: 39] [Article Influence: 13.0] [Reference Citation Analysis]
114 Badakhshi Y, Jin T. Current understanding and controversies on the clinical implications of fibroblast growth factor 21. Crit Rev Clin Lab Sci 2021;58:311-28. [PMID: 33382006 DOI: 10.1080/10408363.2020.1864278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Moro J, Chaumontet C, Even PC, Blais A, Piedcoq J, Gaudichon C, Tomé D, Azzout-Marniche D. Severe protein deficiency induces hepatic expression and systemic level of FGF21 but inhibits its hypothalamic expression in growing rats. Sci Rep 2021;11:12436. [PMID: 34127689 DOI: 10.1038/s41598-021-91274-4] [Reference Citation Analysis]
116 Sun Y, Wang Y, Chen ST, Chen YJ, Shen J, Yao WB, Gao XD, Chen S. Modulation of the Astrocyte-Neuron Lactate Shuttle System contributes to Neuroprotective action of Fibroblast Growth Factor 21. Theranostics 2020;10:8430-45. [PMID: 32724479 DOI: 10.7150/thno.44370] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
117 Xiao M, Tang Y, Wang S, Wang J, Wang J, Guo Y, Zhang J, Gu J. The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms. Front Endocrinol (Lausanne) 2021;12:598008. [PMID: 34349728 DOI: 10.3389/fendo.2021.598008] [Reference Citation Analysis]
118 Xiao F, Guo F. Impacts of essential amino acids on energy balance. Mol Metab 2021;:101393. [PMID: 34785395 DOI: 10.1016/j.molmet.2021.101393] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
119 Eder K, Gessner DK, Ringseis R. Fibroblast growth factor 21 in dairy cows: current knowledge and potential relevance. J Anim Sci Biotechnol 2021;12:97. [PMID: 34517929 DOI: 10.1186/s40104-021-00621-y] [Reference Citation Analysis]
120 Fiorucci S, Distrutti E, Carino A, Zampella A, Biagioli M. Bile acids and their receptors in metabolic disorders. Prog Lipid Res 2021;82:101094. [PMID: 33636214 DOI: 10.1016/j.plipres.2021.101094] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
121 Ennequin G, Sirvent P, Whitham M. Role of exercise-induced hepatokines in metabolic disorders. Am J Physiol Endocrinol Metab 2019;317:E11-24. [PMID: 30964704 DOI: 10.1152/ajpendo.00433.2018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
122 Tomita Y, Lee D, Tsubota K, Kurihara T. PPARα Agonist Oral Therapy in Diabetic Retinopathy. Biomedicines 2020;8:E433. [PMID: 33086679 DOI: 10.3390/biomedicines8100433] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
123 Oost LJ, Kustermann M, Armani A, Blaauw B, Romanello V. Fibroblast growth factor 21 controls mitophagy and muscle mass. J Cachexia Sarcopenia Muscle 2019;10:630-42. [PMID: 30895728 DOI: 10.1002/jcsm.12409] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 20.7] [Reference Citation Analysis]
124 Jiang L, Yin Q, Yang M, Li M, Pan M, Han Y, Zhao Z, Wang Z, Zhu L, Wei Q, Tu Y, Gao M, Liu H, Zhang X, Liu BC, Wang B. Fibroblast Growth Factor 21 Predicts and Promotes Vascular Calcification in Haemodialysis Patients. Kidney Dis (Basel) 2021;7:227-40. [PMID: 34179118 DOI: 10.1159/000512750] [Reference Citation Analysis]
125 Langlois A, Dumond A, Vion J, Pinget M, Bouzakri K. Crosstalk Communications Between Islets Cells and Insulin Target Tissue: The Hidden Face of Iceberg. Front Endocrinol 2022;13:836344. [DOI: 10.3389/fendo.2022.836344] [Reference Citation Analysis]
126 Tomita Y, Fu Z, Wang Z, Cakir B, Cho SS, Britton W, Sun Y, Hellström A, Talukdar S, Smith LEH. Long-Acting FGF21 Inhibits Retinal Vascular Leakage in In Vivo and In Vitro Models. Int J Mol Sci 2020;21:E1188. [PMID: 32054022 DOI: 10.3390/ijms21041188] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
127 [DOI: 10.1101/264234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
128 Lauritzen ES, Svart MV, Voss T, Møller N, Bjerre M. Impact of Acutely Increased Endogenous- and Exogenous Ketone Bodies on FGF21 Levels in Humans. Endocr Res 2021;46:20-7. [PMID: 33074729 DOI: 10.1080/07435800.2020.1831015] [Reference Citation Analysis]
129 Klaus S, Igual Gil C, Ost M. Regulation of diurnal energy balance by mitokines. Cell Mol Life Sci 2021;78:3369-84. [PMID: 33464381 DOI: 10.1007/s00018-020-03748-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
130 Ángel GM, Paola VV, Froylan David MS, Lucía PB, Juan Mauricio VZ, María Fernanda NF, Guadalupe MM, Jorge Ignacio FC, Julia María ZV, Olynka VV, Ricardo CR, Rodolfo RP, Luis E MB, Josefina AG, Berenice RJ, Lizette PR, Malaquías LC, de Los Ángeles MM, Victoria BY, Ángeles EC, Guadalupe LC, Angelina LE, Elizabeth GL, Francisco J GP, Daniel CR. Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease. Ther Adv Endocrinol Metab 2021;12:20420188211001160. [PMID: 33854753 DOI: 10.1177/20420188211001160] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
131 Shan Z, Alvarez-Sola G, Uriarte I, Arechederra M, Fernández-Barrena MG, Berasain C, Ju C, Avila MA. Fibroblast growth factors 19 and 21 in acute liver damage. Ann Transl Med 2018;6:257. [PMID: 30069459 DOI: 10.21037/atm.2018.05.26] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
132 White MF, Kahn CR. Insulin action at a molecular level - 100 years of progress. Mol Metab 2021;:101304. [PMID: 34274528 DOI: 10.1016/j.molmet.2021.101304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
133 Alliouachene S, Kieswich JE, Bilanges B, McCafferty K, Thiemermann C, Vanhaesebroeck B, Yaqoob MM. Uninephrectomy and class II PI3K-C2β inactivation synergistically protect against obesity, insulin resistance and liver steatosis in mice. Am J Transplant 2021;21:2688-97. [PMID: 33370494 DOI: 10.1111/ajt.16470] [Reference Citation Analysis]
134 Arlien-søborg MC, Grøndahl C, Bæk A, Dal J, Madsen M, Høgild ML, Pedersen SB, Bjerre M, Jørgensen JOL. Fibroblast Activation Protein is a GH Target: A Prospective Study of Patients with Acromegaly Before and After Treatment. The Journal of Clinical Endocrinology & Metabolism 2020;105:106-15. [DOI: 10.1210/clinem/dgz033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]